Wells Fargo initiated coverage of Align Technology (ALGN) with an Overweight rating and $255 price target As the market leader in clear aligners with two-thirds market share and strong brand recognition, Align has a “durable and competitive moat,” the analyst tells investors in a research note. The firm believes the market is underpenetrated with 22M people out of a pool of 600M seeking treatment for malocclusion. It estimates Align’s penetration is 10%-11%, leaving “significant runway for long-term, durable growth.” With the stock trading at a 29% discount to its three-year average, Align shares “are poised to run when the market improves,” contends Wells.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALGN:
- Align Technology’s Earnings Call: Record Revenue Amid Challenges
- Align Tech’s Resilience and Strategic Focus Justify Buy Rating Amidst Mixed Results
- Align Technology price target lowered to $272 from $280 at Morgan Stanley
- Align Technology price target lowered to $250 from $276 at Baird
- Align Technology Reports Steady Growth in 2024 Financial Results